Regen BioPharma Inc Stock OTC Bulletin Board
Equities
US75886M1027
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 236K | Sales 2023 | 237K | Capitalization | 6.33M |
---|---|---|---|---|---|
Net income 2022 | 2M | Net income 2023 | 1M | EV / Sales 2022 | 144 x |
Net Debt 2022 | 1.22M | Net Debt 2023 | 635K | EV / Sales 2023 | 29.4 x |
P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.99% |
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |